THE HEPATIC PROGENITOR CELL LINE HUMAN HEPATOCYTES HEPARG FROM BIOPREDIC INTERNATIONAL
Dead / Cancelled — Cancelled — Section 8 (as of 09 Feb 2018)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77752057
- Registration number
- 3990584
- Mark type
- Design + words
- Filed
- 04 Jun 2009
- Published for opposition
- 19 Jan 2010
- Registered
- 05 Jul 2011
- Attorney of record
- Dean R. Karau
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of illness and disease, namely, hepatic diseases and in particular viral hepatitis, metabolic disorders related to insulin-response and lipid overload, iron overload, alcohol-related diseases, hepatic fibrosis, drug-induced hepatic toxicities or those caused by other xenobiotics, cell cultures derived from living organisms and hepatic cell cultures for medical purposes, media for growing cells for medical purposes
Owner
- SARL BIOPREDIC INTERNATIONAL, 35000 Rennes, FR
- SARL BIOPREDIC INTERNATIONAL, 35000 Rennes, FR
- SARL BIOPREDIC INTERNATIONAL, 35000 Rennes, FR
Prosecution history
- 09 Feb 2018 — CANCELLED SEC. 8 (6-YR)
- 05 Jul 2016 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Jul 2011 — REGISTERED-PRINCIPAL REGISTER
- 28 May 2011 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 May 2011 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 26 May 2011 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 May 2011 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 May 2011 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 May 2011 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Apr 2011 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Apr 2011 — NON-FINAL ACTION E-MAILED
- 05 Apr 2011 — SU - NON-FINAL ACTION - WRITTEN
- 04 Apr 2011 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Mar 2011 — USE AMENDMENT FILED
- 31 Mar 2011 — TEAS STATEMENT OF USE RECEIVED